Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis.

Amin R, Noone PG, Ratjen F.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007481. doi: 10.1002/14651858.CD007481.pub3. Review.

PMID:
23235645
2.

Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis.

Amin R, Noone PG, Ratjen F.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007481. doi: 10.1002/14651858.CD007481.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD007481.

PMID:
19370689
3.

Pharmacological agents (anti-inflammatory and analgesic) for managing symptoms in people with cystic fibrosis-related arthritis.

Thornton J, Rangaraj S.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006838. doi: 10.1002/14651858.CD006838.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD006838.

PMID:
18254117
4.

Enteral tube feeding for cystic fibrosis.

Conway SP, Morton A, Wolfe S.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD001198. doi: 10.1002/14651858.CD001198.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001198.

PMID:
18425869
5.

Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Plummer A, Wildman M.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006682. doi: 10.1002/14651858.CD006682.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD006682.

PMID:
21249681
6.

Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Fernandes B, Plummer A, Wildman M.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006682. doi: 10.1002/14651858.CD006682.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD006682.

PMID:
18425963
7.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Wood DM, Smyth AR.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004197. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004197.

PMID:
16437476
8.

Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis.

Thornton J, Rangaraj S.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD007336. doi: 10.1002/14651858.CD007336.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD007336.

PMID:
19160333
9.

Totally implantable vascular access devices for cystic fibrosis.

A-Rahman A, Spencer D.

Cochrane Database Syst Rev. 2003;(3):CD004111. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD004111.

PMID:
12918004
10.

Drug therapies for reducing gastric acidity in people with cystic fibrosis.

Ng SM, Jones AP.

Cochrane Database Syst Rev. 2003;(2):CD003424. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD003424.

PMID:
12804466
11.

Bisphosphonates for osteoporosis in people with cystic fibrosis.

Brenckmann C, Papaioannou A.

Cochrane Database Syst Rev. 2001;(4):CD002010. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD002010.

PMID:
11687132
12.

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.

Jagannath VA, Asokan GV, Fedorowicz Z, Singaram JS, Lee TW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008139. doi: 10.1002/14651858.CD008139.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD008139.

PMID:
20238363
13.

Insulin and oral agents for managing cystic fibrosis-related diabetes.

Onady GM, Stolfi A.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004730. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD004730.

PMID:
16034943
14.

Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Elphick H, Southern K.

Cochrane Database Syst Rev. 2000;(4):CD002204. Review. Update in: Cochrane Database Syst Rev. 2012;6:CD002204.

PMID:
11034746
15.

Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.

Beer H, Southern KW, Swift AC.

Cochrane Database Syst Rev. 2011 May 11;(5):CD008253. doi: 10.1002/14651858.CD008253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD008253.

PMID:
21563167
16.

Vitamin A supplementation for cystic fibrosis.

O'Neil C, Shevill E, Chang AB.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006751. doi: 10.1002/14651858.CD006751.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD006751.

PMID:
18254115
17.

Oral calorie supplements for cystic fibrosis.

Smyth R, Walters S.

Cochrane Database Syst Rev. 2000;(2):CD000406. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD000406.

PMID:
10796716
18.

Oral calorie supplements for cystic fibrosis.

Smyth R, Walters S.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000406. Review. Update in: Cochrane Database Syst Rev. 2012;10:CD000406.

PMID:
17253450
19.

Vitamin K supplementation for cystic fibrosis.

Jagannath VA, Fedorowicz Z, Thaker V, Chang AB.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008482. doi: 10.1002/14651858.CD008482.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD008482.

PMID:
21249710
20.

Newborn screening for cystic fibrosis.

Southern KW, Mérelle MM, Dankert-Roelse JE, Nagelkerke AD.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001402. doi: 10.1002/14651858.CD001402.pub2. Review.

PMID:
19160197

Supplemental Content

Support Center